Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TICAGRELOR vs TILDRAKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TICAGRELOR vs TILDRAKIZUMAB: Safety Overview

Metric TICAGRELOR TILDRAKIZUMAB
Total FAERS Reports 22,885 869
Deaths Reported 2,951 89
Death Rate 12.9% 10.2%
Hospitalizations 8,579 389
Average Patient Age 65.9 yrs 57.9 yrs
% Female Patients 36.7% 42.5%
FDA Approval Date Apr 21, 2023 N/A
Manufacturer Mylan Pharmaceuticals Inc. Sun Pharmaceutical Industries, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A